Skip to main content

Interview with Edward Hsiao MD PhD of UCSF

by Julia Moore, Drake HS

How did you become interested in musculoskeletal disorders?
I’ve always been interested in the skeleton. Although we typically think of bones as being solid and unchanging, they undergo a variety of very significant events throughout our lifetime, including growing and repairing after injury. In addition, bones are central to us as a living organism. They provide structure to our bodies, protect soft or vital organs, allow us to move efficiently, and provides bone marrow space for blood formation. We now know that many medically important diseases including osteoporosis, atherosclerosis, and heterotopic bone ossification are all a result of problems affecting normal bone formation.

How are we currently treating different types of musculoskeletal disorders?
Since we don’t  understand how many musculoskeletal disorders develop, our ability to prevent them is pretty limited. Treatments for established disease are also very rudimentary and mostly symptomatic. For example, many inherited diseases of the bone can only be treated by surgery to remove the affected bone. In some cases, we can use metal implants or joint replacement, but these have a relatively short lifespan. Even common diseases, such as osteoporosis or arthritis, have only limited medical treatments.

How do you do your research?
My research is driven by a desire to understand how hormones and genetics control human skeletal growth. Since getting samples of diseased tissues from patients is often difficult, I use a variety of model systems to study skeletal disease. This includes mouse models where I can control hormone signals, and human stem cells created from patients with genetic skeletal diseases (human induced pluripotent stem cells). Together, these models are helping us understand what causes disease and how we can develop new treatments.

What are artificial hormones and how are they advancing research and treatment?
Nature uses hormones as a way to communicate between different parts of the body. One major class of hormone molecules is called G-protein coupled receptors (GPCRs). Since there are over 500 GPCRs in the human genome, figuring out what each individual receptor does is a huge challenge. Our strategy uses a synthetic receptor that only responds to a synthetic drug. This system acts like an artificial hormone – if we add the drug, we can turn the system on; if we take away the drug, we can turn it off. This system allows us to “mimic” a normal hormone system and control that pathway using our drug. This model has proven useful for studying hormone signaling in complex organ systems, including cardiac disease, the brain, and now bone.

What do you think is the future of treatment and prevention of musculoskeletal disorders?
I think that developing robust prevention strategies is important. We also need to develop better combinations of surgical and medical management that have fewer side effects. Much of this can be gained by a better understanding of what happens in normal growth and how those mechanisms go wrong in disease. Finally, I believe that human stem cells provide a valuable new tool in this effort by allowing us to study lab-derived human tissues directly. These stem cells are already providing insights into some rare and dramatic bone diseases. We hope to be able to extend our findings to more common disorders.

Edward Hsiao will be speaking at Terra Linda High School in Room 207 on
Wednesday February 29th at 7:30-8:30pm

Written by: Julia Moore 

Post a Comment

Popular posts from this blog

Bacteria, Botulism, and Beauty

--> By Talya Klinger, MSS Intern
What do foodborne illnesses, neck dystonia treatments, and celebrities’ beauty regimens have in common? Clostridium botulinum, baratii, and other species of Clostridium bacteria produce all of the above and more. These seemingly innocuous, rod-shaped bacteria, commonly found in soil and in the intestinal tracts of fish and mammals, produce one of the most deadly biological substances: botulinum toxin, a neurotoxin that intercepts neurotransmitters and paralyzes muscles in the disease known as botulism. Nonetheless, botulinum toxin isn’t all bad: this chemical not only protects the bacteria from intense heat and high acidity, but it makes for an effective treatment for medical conditions as wide-ranging as muscle spasms, chronic migraines, and, yes, wrinkles. 

Clostridium botulinum and similar bacteria can make their way into the human body in a number of ways. Wounds infected with Clostridium botulinum or spores ingested by infants can lead to …

An Interview With Diara Spain, Ph.D

By Rachael Metzger, MSS Intern

Ocean acidification is an issue becoming apparent in the effects on both sea creatures and humans. Diara Spain, the Associate Professor of Biology at Dominican University, came to Marin Science Seminar to talk to us about her studies in marine invertebrates and the damage ocean acidification is causing them. 

To learn more about Diara Spain and what inspired her studies we conducted an interview:

1. How did you get interested in biology? Is there a time, event, 
or person in your life that inspired you to pursue the study? I've always been interested in biology, really science in general. I grew up in rural North Carolina and as a kid it was expected that you'd spend most of your free time outside playing with your friends and pets.  One thing that sparked my interest in marine organisms were the summer vacations at the undeveloped beaches in North Carolina. 
2. Why did you specifically decide to focus on functional morphology, locomotion in echinode…

Invention in Medicine this Wed. 10/26/16

Marin Science Seminar for Teens & Community Presents Invention in Medicine How Medical Devices get Invented and Go to Market with Art Wallace MD PhD of UCSF & VAMC SF
Wednesday, October 26, 2016 7:30 - 8:30 pm Terra Linda High School, Room 207 320 Nova Albion, San Rafael, CA 94903 

Art Wallace started out in experimental surgery and radiology studying imaging of the heart using CT
scanners. He has worked on a number of devices that originally were built for experimental studies that evolved into clinically useful devices including a cardiac output monitor, the off pump CABG, off pump aneurysm surgery, electronic sedation, and a selective coronary vasodialtor. Dr. Wallace will explain his experiences with the inventive process using examples from both device design and drug development. There will be a brief discussion of the importance of intellectual property, patents, venture capital, FDA approval, and business development in completing the invention process. There will …